Pycard Asc Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The PYCARD/ASC Protein is a protein involved in various cellular processes relevant to neurodegenerative diseases. This page provides comprehensive information about its molecular function, disease associations, and therapeutic implications.
| PYCARD/ASC Protein |
|---|
| Gene | PYCARD |
| UniProt ID | Q9ULZ9 |
| PDB IDs | 2Z33, 3Y63 |
| Molecular Weight | 22 kDa |
| Subcellular Localization | Cytoplasm (inflammasome specks) |
| Protein Family | PYD/CARD adaptor family |
PYCARD (ASC) is a key adaptor protein that bridges inflammasome sensors with caspase-1, essential for inflammasome assembly and pyroptosis.
PYCARD (ASC) structure:
PYD Domain (N-terminal, 1-93 aa):
- Pyrin domain
- Six α-helices in 3D fold
- Homotypic PYD-PYD interactions
- Critical for sensor recruitment
CARD Domain (C-terminal, 154-219 aa):
- Caspase recruitment domain
- Six α-helices
- Homotypic CARD-CARD interactions
- Pro-caspase-1 recruitment
Linker:
- Proline-rich region
- Flexible
PYCARD functions as the central adaptor in inflammasome signaling.
Inflammasome Assembly:
- Sensor proteins (NLRP1, NLRP3, NLRC4, AIM2) detect danger
- Sensors oligomerize via their PYD/NBD domains
- PYCARD PYD binds sensor PYD
- PYCARD CARD recruits pro-caspase-1
- Proximity induces caspase-1 activation
ASC Specks:
- Large protein aggregates (1-2 μm)
- Form upon inflammasome activation
- Release from cells
- Propagate inflammation
- Can be detected as biomarkers
Alzheimer's Disease:
- ASC specks in AD brain
- NLRP3/ASC/Caspase-1 axis
- Promotes Aβ pathology
- Therapeutic target
Parkinson's Disease:
- ASC released from microglia
- Spreads α-synuclein pathology
- NLRP3 inflammasome activation
- Dopaminergic vulnerability
ALS:
- ASC specks in spinal cord
- TDP-43 activates inflammasome
- Motor neuron death
- Biomarker potential
Inhibitors:
- Small molecule ASC inhibitors
- PYD-domain blockers
- CARD-domain blockers
Research Tools:
- ASC knockout mice
- Fluorescent ASC constructs
- ASC specks detection assays
The study of Pycard Asc Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PubMed
- PubMed
- PubMed
- PubMed
- PubMed
- PubMed
- PubMed
- PubMed
The PYCARD (ASC) protein plays a central role in canonical inflammasome signaling:
Sensor Activation
- NLRP1, NLRP3, NLRC4, and AIM2 detect pathogens and damage
- Sensors undergo conformational changes and oligomerization
- ATP binding/hydrolysis often required for NLR activation
ASC Recruitment
- Homotypic PYD-PYD interactions between sensor and ASC
- ASC nucleates into filamentous structures
- Creates platform for caspase-1 recruitment
Caspase-1 Activation
- Proximity-induced autoproteolysis
- Active caspase-1 tetramer formation
- Substrate cleavage and pro-inflammatory cytokine release
ASC forms distinctive specks (1-2 μm diameter):
- Visible by microscopy
- Released from activated cells
- Can be detected in extracellular space
- Propagate inflammation to neighboring cells
- Serve as biomarkers for inflammasome activation
- Amyloid-β Activation: Aβ triggers NLRP3/ASC inflammasome
- ASC Speck Release: Detected in AD brain and CSF
- Interleukin-1β: Elevated IL-1β drives neuroinflammation
- Tau Pathology: IL-1β promotes tau phosphorylation
- α-Synuclein activates NLRP3 inflammasome
- ASC specks spread pathology
- Microglial activation amplifies dopaminergic death
- IL-1β and IL-18 levels elevated in PD
- TDP-43 pathology triggers inflammasome
- ASC specks in motor cortex and spinal cord
- Mutations in NLRP1 associated with ALS
- Correlation with disease progression
| Target |
Compound |
Stage |
| ASC PYD |
MCC950 |
Preclinical |
| Caspase-1 |
VX-765 |
Clinical |
| NLRP3 |
Dabzat |
Research |
- ASC knockdown approaches
- CRISPR-based editing
- Viral vector delivery to CNS
- Detected in CSF of AD/PD patients
- Reflects active neuroinflammation
- Potential for disease progression monitoring
- IL-1β and IL-18 as downstream markers
- Correlate with ASC activation
- Therapeutic response indicators
- Immunohistochemistry for ASC specks
- ELISA for ASC in CSF
- Flow cytometry for cell-specific activation
- Live-cell imaging of ASC speck formation
- ASC knockout mice
- Primary neuronal cultures
- iPSC-derived neurons and microglia
- Organotypic brain slice cultures